<Disease><Name>BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2 (CBAS2)</Name><Synonym>CHOLESTASIS WITH DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE DEFICIENCY</Synonym><OMIM><Number>235555</Number><URL>http://omim.org/entry/235555</URL></OMIM><Orphanet><Number>79303</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79303</URL></Orphanet><Protein><Number>3-oxo-5-beta-steroid 4-dehydrogenase</Number><URL>http://www.uniprot.org/uniprot/P51857</URL></Protein><ExPASy><Number>1.3.1.3</Number><URL>http://enzyme.expasy.org/EC/1.3.1.3</URL></ExPASy><Gene>7q33</Gene><ICD>K76.8</ICD><Summary>rare (~30 cases) ;autosomal recessive;mutation in the AKR1D1 gene</Summary><Symptoms><symtomp><id>2257</id><symptom>cholestasis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3978</id><symptom>giant cell hepatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1873</id><symptom>jaundice</symptom><category>LABORATORY FINDINGS | SKIN</category></symtomp><symtomp><id>2380</id><symptom>liver failure</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>2111</id><name>Cholic acid</name><specimen>plasma</specimen><value>decreased</value><min>0.05</min><max>0.45</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2112</id><name>Chenodeoxycholic acid</name><specimen>plasma</specimen><value>decreased</value><min>0.22</min><max>12.40</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1183</id><name>Albumin</name><specimen>plasma</specimen><value>normal/dec</value><min>25.00</min><max>34.00</max><unit>g/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>315</id><name>Bilirubin</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>200.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>317</id><name>Bilirubin</name><specimen>serum</specimen><value>increased</value><min>3.40</min><max>17.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>318</id><name>Bilirubin</name><specimen>serum</specimen><value>increased</value><min>3.40</min><max>17.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1202</id><name>Bilirubin</name><specimen>bile</specimen><value>increased</value><min>50.00</min><max>100.00</max><unit>mg/dl</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>316</id><name>Bilirubin</name><specimen>serum</specimen><value>increased</value><min>3.40</min><max>17.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>normal decreased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>normal decreased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>normal decreased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>normal decreased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>normal decreased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1041</id><name>Phosphatase, alkaline</name><specimen>serum</specimen><value>normal/inc</value><min>60.00</min><max>170.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1042</id><name>Phosphatase, alkaline</name><specimen>serum</specimen><value>normal/inc</value><min>20.00</min><max>150.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7348</id><title>AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases</title><author>Chen JY,</author><journal>Pediatr Neonatol</journal><year>2020</year><book /><volume>61</volume><number>1</number><pages>75-83</pages><co_aut>et al.</co_aut></literature><literature><id>4318</id><title>In-Depth Dissection of the P133R Mutation in Steroid 5&#946;-Reductase (AKR1D1): A Molecular Basis of Bile Acid Deficiency</title><author>Chen M,</author><journal>Biochemistry</journal><year>2015</year><book /><volume>54</volume><number>41</number><pages>6343-6351</pages><co_aut>Jin Y, Penning TM</co_aut></literature><literature><id>4319</id><title>Distinguishing primary from secondary &#916;(4) -3-oxosteroid 5&#946;-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis</title><author>Yanagi T,</author><journal>Clin Endocrinol (Oxf)</journal><year>2015</year><book /><volume>82</volume><number>3</number><pages>346-351</pages><co_aut>et al.</co_aut></literature><literature><id>4320</id><title>5&#946;-Reduced steroids and human &#916;(4)-3-ketosteroid 5&#946;-reductase (AKR1D1)</title><author>Chen M,</author><journal>Steroids</journal><year>2014</year><book /><volume>83</volume><number>0</number><pages>17-26</pages><co_aut>Penning TM</co_aut></literature><literature><id>4321</id><title>A combination of mutations in AKR1D1 and SKIV2L in a family with severe infantile liver disease</title><author>Morgan NV,</author><journal>Orphanet J Rare Dis</journal><year>2013</year><book /><volume>8</volume><number>0</number><pages>74</pages><co_aut>et al.</co_aut></literature><literature><id>4322</id><title>Two neonatal cholestasis patients with mutations in the SRD5B1 (AKR1D1) gene: diagnosis and bile acid profiles during chenodeox</title><author>Seki Y,</author><journal>J Inherit Metab Dis</journal><year>2013</year><book /><volume>36</volume><number>3</number><pages>565-573</pages><co_aut>et al.</co_aut></literature><literature><id>4323</id><title>Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency</title><author>Drury JE,</author><journal>J Biol Chem</journal><year>2010</year><book /><volume>285</volume><number>32</number><pages>24529-37</pages><co_aut>Mindnich R, Penning TM</co_aut></literature><literature><id>4325</id><title>Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infanc</title><author>Lemonde HA,</author><journal>Gut</journal><year>2003</year><book /><volume>52</volume><number>10</number><pages>1494-1499</pages><co_aut>et al.</co_aut></literature><literature><id>4324</id><title>Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic aci</title><author>Clayton PT,</author><journal>Gut</journal><year>1996</year><book /><volume>38</volume><number>4</number><pages>623-628</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>